会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Condensed-Indan derivatives and pharmaceutically acceptable salts thereof
    • 缩合 - 茚满衍生物及其药学上可接受的盐
    • US5733918A
    • 1998-03-31
    • US578542
    • 1996-01-19
    • Shinji OkazakiTetsuji AsaoMotoji WakidaKeisuke IshidaMasato WashinosuTeruhiro UtsugiYuji Yamada
    • Shinji OkazakiTetsuji AsaoMotoji WakidaKeisuke IshidaMasato WashinosuTeruhiro UtsugiYuji Yamada
    • A61K31/44A61K31/473A61P35/00C07D221/18C07D401/12C07D491/04C07D491/056C07D521/00A61K31/47C07D491/56
    • C07D231/12C07D221/18C07D233/56C07D249/08C07D401/12C07D491/04
    • A condensed-indan derivative represented by formula (1) and a pharmaceutically acceptable salt thereof: ##STR1## wherein ring A represents an optionally substituted benzene ring or naphthalene ring, or a benzene ring having a lower alkylenedioxy group, ring B represents an optionally substituted benzene ring or a benzene ring having a lower alkylenedioxy group. Y represents --N.dbd.CR-- or --CR=N--, R represents a --NR.sub.1 R.sub.2 group, an optionally substituted nitrogen-containing heterocyclic group or a --OR.sub.3 group, wherein R.sub.1 and R.sub.2 are the same or different and each is a hydrogen atom; a phenyl group; an optionally substituted nitrogen-containing heterocyclic group; or a lower alkyl group which may be substituted by at least one selected from the group consisting of an optionally substituted amino group, a lower alkoxy group, a phenyl group, a nitrogen-containing heterocyclic group, an amine oxide group substituted by a lower alkyl group or a hydroxyl group(s); R.sub.3 represents a lower alkyl group optionally substituted by a substituted amino group, except when R represents an optionally substituted nitrogen-containing heterocyclic group; ring A and ring B are a benzene ring having no substituent group.
    • PCT No.PCT / JP95 / 00944 Sec。 371日期1996年1月19日 102(e)日期1996年1月19日PCT提交1995年5月18日PCT公布。 出版物WO95 / 32187 日期:1995年11月30日由式(1)表示的缩合 - 缩水甘油衍生物及其药学上可接受的盐:其中环A表示任选取代的苯环或萘环,或具有低级亚烷基二氧基 基团,环B表示任选取代的苯环或具有较低亚烷基二氧基的苯环。 Y表示-N = CR-或-CR = N-,R表示-NR1R2基,任选取代的含氮杂环基或-OR 3基,其中R1和R2相同或不同,各自为氢原子 ; 苯基; 任选取代的含氮杂环基; 或可以被选自任选取代的氨基,低级烷氧基,苯基,含氮杂环基,被低级烷基取代的氧化胺基中的至少一种取代的低级烷基 基团或羟基; R3表示任选被取代的氨基取代的低级烷基,除了当R表示任意取代的含氮杂环基时; 环A和环B是没有取代基的苯环。
    • 3. 发明授权
    • Condensed indan derivatives and salts thereof
    • 稠合茚满衍生物及其盐
    • US5763453A
    • 1998-06-09
    • US809602
    • 1997-04-03
    • Shinji OkazakiTetsuji AsaoTeruhiro UtsugiYuji Yamada
    • Shinji OkazakiTetsuji AsaoTeruhiro UtsugiYuji Yamada
    • A61K31/47A61K31/473A61P35/00C07D221/18C07D401/04C07D491/056
    • C07D401/04C07D221/18
    • A condensed indan derivative represented by the formula (1) ##STR1## wherein the ring A is an optionally substituted benzene ring or a benzene ring which has lower alkylenedioxy group(s), the ring B is an optionally substituted benzene ring or a benzene ring which has lower alkylene dioxy group(s), and R is a group --NR.sub.1 R.sub.2, an optionally substituted nitrogen-containing heterocyclic group, a group --OR.sub.3 or a group --SR.sub.4 (wherein R.sub.1 and R.sub.2 are the same or different and each represent a hydrogen atom, a phenyl group, an optionally substituted nitrogen-containing heterocyclic group, or a lower alkyl group which may be substituted by optionally substituted amino group(s), lower alkoxy group(s), phenyl group(s), nitrogen-containing heterocyclic group(s) or hydroxyl group(s), and R.sub.3 and R.sub.4 each represent a lower alkyl group which may be substituted by substituted amino group(s)), provided that at least one of the rings A and B is a substituted benzene ring and R is not --NHCH.sub.3, and salts thereof, and medical use of said derivative and salts.
    • PCT No.PCT / JP96 / 02195 Sec。 371日期1997年4月3日 102(e)日期1997年4月3日PCT提交1996年8月2日PCT公布。 公开号WO97 / 06145 日本公报1997年2月20日由式(1)表示的缩合茚满衍生物(1)其中环A为任选取代的苯环或具有低亚烷基二氧基的苯环,环B为 任选取代的苯环或具有低级亚烷基二氧基的苯环,R为基团-NR1R2,任选取代的含氮杂环基,-OR3基或-SR4基(其中R1和R2为 相同或不同,各自表示氢原子,苯基,任选取代的含氮杂环基或可被任选取代的氨基取代的低级烷基,低级烷氧基,苯基 基团,含氮杂环基或羟基,R 3和R 4各自表示可以被取代的氨基取代的低级烷基),条件是至少一个 环A和B是取代的苯环,R不是-NHCH 3及其盐,以及所述衍生物和盐的医疗用途。